NO972771D0 - Ny reseptor - Google Patents

Ny reseptor

Info

Publication number
NO972771D0
NO972771D0 NO972771A NO972771A NO972771D0 NO 972771 D0 NO972771 D0 NO 972771D0 NO 972771 A NO972771 A NO 972771A NO 972771 A NO972771 A NO 972771A NO 972771 D0 NO972771 D0 NO 972771D0
Authority
NO
Norway
Prior art keywords
new receptor
receptor
new
Prior art date
Application number
NO972771A
Other languages
English (en)
Other versions
NO972771L (no
Inventor
Hugh Jonathan Herdon
Jeffrey Clifford Jerman
Wai Ngor Chan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO972771D0 publication Critical patent/NO972771D0/no
Publication of NO972771L publication Critical patent/NO972771L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO972771A 1994-12-17 1997-06-16 Ny reseptor NO972771L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9425502.3A GB9425502D0 (en) 1994-12-17 1994-12-17 Novel receptor
PCT/EP1995/004998 WO1996018650A1 (en) 1994-12-17 1995-12-11 Novel receptor

Publications (2)

Publication Number Publication Date
NO972771D0 true NO972771D0 (no) 1997-06-16
NO972771L NO972771L (no) 1997-08-15

Family

ID=10766105

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972771A NO972771L (no) 1994-12-17 1997-06-16 Ny reseptor

Country Status (15)

Country Link
US (1) US5985334A (no)
EP (1) EP0807122A1 (no)
JP (1) JPH10511083A (no)
CN (1) CN1175262A (no)
AU (1) AU710150B2 (no)
BR (1) BR9510060A (no)
CA (1) CA2207921A1 (no)
CZ (1) CZ187697A3 (no)
FI (1) FI972558A0 (no)
GB (1) GB9425502D0 (no)
HU (1) HUT77077A (no)
NO (1) NO972771L (no)
NZ (1) NZ298059A (no)
PL (1) PL320747A1 (no)
WO (1) WO1996018650A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245893B1 (en) * 1994-12-17 2001-06-12 Smithkline Beecham P.L.C. Receptor that binds anti-convulsant compounds
CA3168730A1 (en) * 2020-03-10 2021-09-16 Heather BUCKLEY Light-activated pathogen-killing molecules and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
GB9225860D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
EP0665887B1 (en) * 1993-08-20 1998-10-14 Smithkline Beecham Plc Human 5-ht 2? receptor

Also Published As

Publication number Publication date
HUT77077A (hu) 1998-03-02
CA2207921A1 (en) 1996-06-20
JPH10511083A (ja) 1998-10-27
AU710150B2 (en) 1999-09-16
BR9510060A (pt) 1998-06-02
US5985334A (en) 1999-11-16
FI972558A7 (fi) 1997-06-16
MX9704560A (es) 1997-10-31
PL320747A1 (en) 1997-10-27
CZ187697A3 (en) 1997-10-15
NO972771L (no) 1997-08-15
NZ298059A (en) 2000-03-27
WO1996018650A1 (en) 1996-06-20
FI972558L (fi) 1997-06-16
FI972558A0 (fi) 1997-06-16
AU4345896A (en) 1996-07-03
CN1175262A (zh) 1998-03-04
GB9425502D0 (en) 1995-02-15
EP0807122A1 (en) 1997-11-19

Similar Documents

Publication Publication Date Title
FI953303A0 (fi) Uusi fytaasi
NO993575L (no) Ny anordning
NO20001830D0 (no) Ny kombinasjon
FI972194A7 (fi) Uusia bentsyylipyrimidiinejä
FI954008L (fi) Substituoituja bifenyyli-isoksatsolisulfoniamideja
FI951908A7 (fi) Substituoituja pyridyylipyratsoleja
FI955927A7 (fi) Substituoidut 1H-imidatsolit
NO982732D0 (no) Ny fremgangsmÕte
ATA163695A (de) 2-hydroxyphenyltriazine
NO982414D0 (no) Ny kombinasjon
DE69534718D1 (de) Substituierte 9-alkyladenine
NO970740D0 (no) Glutamat reseptor
FI953710L (fi) Uusia pyrrolokarbatsoleja
NO993298L (no) Ny fremgangsmÕte
DE69535345D1 (de) Fixiergerät
NO995796L (no) Ny fremgangsmåte
DE69702724D1 (de) Vibrator
BR9509559A (pt) Azolilulsolfonilfeniluracilas substituídas
DE69431672D1 (de) Adrenergischer rezeptor
BR9711681A (pt) Novos m-todos
FI972558A7 (fi) Uusi reseptori
FI964026A0 (fi) Hierontalaite
DE59510274D1 (de) Substituierte biphenyloxazoline
KR970702876A (ko) 뉴로키닌 길항제(Neurokinine (tachykinine) antagonists)
KR950027351U (ko) 반목 항타장치

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application